Gastrointestinal stromal tumors and second primary malignancies before and after the introduction of imatinib mesylate

被引：1

作者：

Jacopo Giuliani ^{[1
]}

Andrea Bonetti ^{[1
]}

机构：

[1] Department of Oncology,Mater Salutis Hospital-ASL 21 della Regione Veneto,Legnago (VR),Italy

来源：

Chinese Journal of Cancer Research | 2013年 / 25卷 / 05期

关键词：

GIST; Gastrointestinal stromal tumors and second primary malignancies before and after the introduction of imatinib mesylate;

D O I：

暂无

中图分类号：

R735 [消化系肿瘤];

学科分类号：

100214 ;

摘要：

Gastrointestinal stromal tumor(GIST)is the most common mesenchymal malignancy of the gastrointestinal tract.GISTs may coexist with different types of cancer,either synchronous or metachronous(1).Most GISTs develop in a sporadic fashion,but familial occurrence,such as neurofibromatosis and Carney-triad,has also been reported(2).The overall frequency of second tumors in different series varied from

引用

页码：486 / 487

页数：2

共 50 条

[11] Adjuvant therapy with imatinib mesylate after resection of primary high-risk gastrointestinal stromal tumors in Japanese patients
Kanda, Tatsuo
Nishida, Toshirou
Wada, Norihito
Kobayashi, Osamu
Yamamoto, Masakazu
Sawaki, Akira
Boku, Narikazu
Koseki, Masato
Doi, Toshihiko
Toh, Yasushi
Kakeji, Yoshihiro
Sugiyama, Toshiro
Komatsu, Yoshito
Kikuchi, Shojiro
Ogoshi, Kyoji
Katai, Hitoshi
Miyachi, Kazuhito
Hirota, Seiichi
Ohtsu, Atsushi
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (01) : 38 - 45
[12] The DREAM complex in antitumor activity of imatinib mesylate in gastrointestinal stromal tumors
DeCaprio, James A.
Duensing, Anette
CURRENT OPINION IN ONCOLOGY, 2014, 26 (04) : 415 - 421
[13] Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)
Sumin Tang
Yuan Yin
Chaoyong Shen
Jiaju Chen
Xiaonan Yin
Bo Zhang
Yuqin Yao
Jinliang Yang
Zhixin Chen
World Journal of Surgical Oncology, 15
[14] CT evaluation of gastrointestinal stromal tumors treated with imatinib mesylate - Reply
Choi, H
Johnson, MM
AMERICAN JOURNAL OF ROENTGENOLOGY, 2005, 185 (05) : 1366 - 1367
[15] One institutional experience with imatinib mesylate in the treatment of gastrointestinal stromal tumors
Tamas, Karin R.
Papai, Zsuzsa
Vegh, Eva A.
Petranyi, Agota E.
Szucs, Zoltan
Rohanszky, Magda
Aranyi, Zsuzsa
Bodoky, Gyorgy
ANNALS OF ONCOLOGY, 2006, 17 : 164 - 164
[16] Clinical response to imatinib mesylate in recurrent and metastatic gastrointestinal stromal tumors
Villalobos, R.
Hernandez, G.
Martinez-Prieto, M.
Silva, A.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[17] Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)
Tang, Sumin
Yin, Yuan
Shen, Chaoyong
Chen, Jiaju
Yin, Xiaonan
Zhang, Bo
Yao, Yuqin
Yang, Jinliang
Chen, Zhixin
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2017, 15
[18] Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate
Wu, Ting-Jung
Lee, Li-Yu
Yeh, Chun-Nan
Wu, Pei-Yu
Chao, Tzu-Chieh
Hwang, Tsann-Long
Jan, Yi-Yin
Chen, Miin-Fu
BMC GASTROENTEROLOGY, 2006, 6 (1)
[19] Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate
Ting-Jung Wu
Li-Yu Lee
Chun-Nan Yeh
Pei-Yu Wu
Tzu-Chieh Chao
Tsann-Long Hwang
Yi-Yin Jan
Miin-Fu Chen
BMC Gastroenterology, 6
[20] Imaging characteristics of liver metastasis from gastrointestinal stromal tumor before and after imatinib mesylate treatment
Ulusan, Serife
Koc, Zafer
Kayaselcuk, Fazilet
TURKISH JOURNAL OF GASTROENTEROLOGY, 2008, 19 (02): : 129 - 132

← 1 2 3 4 5 →